Norma Verdolini
Overview
Explore the profile of Norma Verdolini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
125
Citations
762
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Serra-Navarro M, Clougher D, Oliva V, Valenzuela-Pascual C, De Prisco M, Forte M, et al.
Eur Psychiatry
. 2025 Mar;
:1-41.
PMID: 40040587
No abstract available.
2.
Verdolini N, Huber R, Morton E, Van Rheenen T, Fries G, Dean O, et al.
Bipolar Disord
. 2025 Feb;
PMID: 39968653
No abstract available.
3.
Fares-Otero N, Verdolini N, Melero H, Andres-Camazon P, Vilajosana E, Cavone V, et al.
Psychol Med
. 2024 Dec;
:1-14.
PMID: 39679545
Background: Both childhood adversity (CA) and first-episode psychosis (FEP) have been linked to alterations in cortical thickness (CT). The interactive effects between different types of CAs and FEP on CT...
4.
Solmi M, Thompson T, Cortese S, Estrade A, Agorastos A, Radua J, et al.
J Am Acad Child Adolesc Psychiatry
. 2024 Nov;
PMID: 39581373
Objective: To identify the COVID-19 pandemic impact on well-being/mental health, coping strategies, and risk factors in adolescents worldwide. Method: This study was based on an anonymous online multi-national/multi-language survey in...
5.
Fortea L, Ortuno M, De Prisco M, Oliva V, Albajes-Eizagirre A, Fortea A, et al.
Biol Psychiatry
. 2024 Nov;
PMID: 39491638
Background: Regional gray matter volume (GMV) differences between individuals with mental disorders and comparison participants may be confounded by co-occurring disorders. To disentangle disorder-specific GMV correlates, we conducted a large-scale...
6.
Palacios-Garran R, Amoretti S, Serra-Navarro M, Torrent C, Garriga M, Fares-Otero N, et al.
J Affect Disord
. 2024 Oct;
369:449-461.
PMID: 39368778
Objective: This study was aimed at identifying sex differences in patients presenting a first episode mania (FEM) or psychosis (FEP) to help shaping early treatment strategies focused on sex differences....
7.
Solmi M, Thompson T, Cortese S, Estrade A, Agorastos A, Radua J, et al.
Eur Neuropsychopharmacol
. 2024 Sep;
90:1-15.
PMID: 39341043
There is no multi-country/multi-language study testing a-priori multivariable associations between non-modifiable/modifiable factors and validated wellbeing/multidimensional mental health outcomes before/during the COVID-19 pandemic. Moreover, studies during COVID-19 pandemic generally do not...
8.
Solmi M, Thompson T, Estrade A, Agorastos A, Radua J, Cortese S, et al.
Psychiatry Res
. 2024 Sep;
342:115972.
PMID: 39305825
International studies measuring wellbeing/multidimensional mental health before/ during the COVID-19 pandemic, including representative samples for >2 years, identifying risk groups and coping strategies are lacking. COH-FIT is an online, international,...
9.
Sex differences in prolactin levels and clinical outcomes in patients with a first psychotic episode
Jorda-Baleri T, Garriga M, Mezquida G, Cuesta M, Martinez-Aran A, Garcia-Rizo C, et al.
Psychoneuroendocrinology
. 2024 Aug;
169:107112.
PMID: 39106582
Aim: To analyze the clinical, neurocognitive, and functional impact of prolactin levels according to sex in patients with a First Episode Psychosis (FEP). Methods: We measured prolactin levels in 221...
10.
Douglas K, Sperry S, Dean O, Fries G, Gomes F, Pavon J, et al.
Bipolar Disord
. 2024 Apr;
26(3):211-215.
PMID: 38622803
No abstract available.